3,3-Dimethyldihydro-2H-pyran-2,6(3H)-dione, 98%, 50g

5-Chloro-2,3-dimethyl-1H-indole, 95.0%, 10g

4-Bromo-1H-indol-5-amine, 97%, 1g

(S)-1-Boc-2-Methylpiperazine hydrochloride, 95.0%, 1g

(S)-2-Amino-3-(4-fluoro-3-hydroxyphenyl)propanoic acid hydrochloride, 98%, 100mg

(1R,2R)-METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOPROPANECARBOXYLATE, 95.0%, 100mg

5-(2,6-Dichloropyrimidin-4-yl)piperidin-2-one, 95.0%, 250mg

5-Methoxy-4-methylnicotinic acid, 95.0%, 1g

tert-Butyl 4-(1-hydroxypropan-2-yl)piperazine-1-carboxylate, 98%, 500mg

2-Phenoxyethylamine>98.0%(GC)25g

boc-b-homo-ser(bzl)-oh, 95.0%, 250mg

8-N-Boc-amino-1,4-dioxa-spiro[4.5]decane-8-carboxylic acid, 97.0%, 5g

GC capillary column ROTI®Cap-1701, 25 m, 0.32 mm, 0.50 µm, 1 Piece(s)